Histamine H4 Receptor

A Potential Novel Therapeutic Target in Oral Lichen Planus and Oral Tongue Cancer

Forskningsoutput: AvhandlingDoktorsavhandlingSamling av artiklar

Sammanfattning

Background and objective: Oral lichen planus (OLP) is a common immune disorder of the oral mucosa, which is categorized as an oral potentially malignant disorder (OPMD) to highlight its potential progression to oral cancer. Oral cancer commonly affects the mobile tongue as oral tongue squamous cell carcinoma (OTSCC), which has dismal prognosis. Histamine signals via four G protein-coupled histamine receptors (H1R-H4R). Classical H1R and H2R medications are ineffective in treating OLP or OTSCC patients. The discovery of H4R has paved the way for novel perspectives in histamine research by modulating immune responses. We therefore hypothesized that H4R is involved in the pathogenesis of OLP and may contribute to oral carcinogenesis. Materials and methods: Tissue samples from OLP, oral epithelial dysplasia (OED) and OTSCC patients, and from healthy control participants were utilized. The in vitro experiments were performed on normal human oral keratinocytes (HOKs), two OTSCC-derived cell lines (HSC-3 and SCC-25), normal salivary gland cells, in addition to supernatants from activated human mast cells (MCs). For in vitro internalization and functional assays, two specific H4R ligands (agonist HST-10, and inverse agonist ST-1007) were used. Protein expression of histamine receptors, transporters and metabolizing enzymes, and other antigens were assessed in tissue samples and cell lines by immunohistochemistry and immunofluorescence staining. The expression levels of mRNA were quantified by qRT-PCR and the highly-sensitive droplet-digital PCR technology. Western blotting assays were performed to assess apoptotic markers following H4R stimulation, while flow cytometry was used to study Annexin-V and PI labelling of dead cells. Histamine levels were analysed using high-performance liquid chromatography. Results: Briefly, H4R is expressed in healthy oral epithelial cells on mRNA and protein levels, and they were able to fully internalize H4R-ligands in a time-dependent manner. In contrast, samples from OLP, OED and OTSCC patients exhibited lower H4R level, which was negatively correlated with MC-count and OTSCC-grade. We also reported that normal HOKs are histamine-producing cells—fully equipped with histamine synthesizing, transporting and degrading molecules. Interestingly, OLP samples exhibit high levels of the histamine synthesizing and transporting molecules, whereas histamine degrading enzyme was strongly inhibited. HOKs showed a dose-dependent Lipopolysaccharides (LPS)-driven release of histamine, while high histamine levels inhibited epithelial adhesion molecules. We next showed that toll-like receptors (TLRs) are essential players in OLP. TLRs were upregulated in OLP lesions, particularly for TLR4, which is necessary for LPS signalling. Importantly, LPS and MC-mediators regulated several oral oncogenes, while H4R-stimulated cells revealed a marked resistance to apoptosis. Furthermore, LPS and histamine influenced human beta defensin 2 (hBD-2) expression, which was highly induced in OLP. Unexpectedly, hBD-2 protein was subsided in OTSCC tissues with a marked downregulation of its transcript in cancer cells. Histamine synergistically induced TNF-α- and IFN-γ-mediated hBD-2 production in HOKs. Interestingly, targeting H4R seems to regulate TNFα- and LPS-mediated expression of hBD-2. Conclusions: Briefly, human oral epithelial cells are “non-professional” histamine producing cells—capable to synthesize, release, and degrade low levels of endogenic histamine. High levels of histamine may downregulate H4R as well as key integrity molecules in HOKs and may enhance subsequent bacterial invasion in OLP. In this regard, our findings suggest a potential role of TLRs in OLP pathogenesis, by mediating LPS signalling and enhancing further immune response and histamine production. In addition, our results indicate that histamine/H4R crosstalk signalling with LPS and MCs could in part be involved in OLP and the potential inflammation-driven tumorigenesis. This was further supported by the ability of H4R to regulate cell apoptosis and modulate antibacterial response in HOKs. Further functional and preclinical studies are therefore warranted.
Originalspråkengelska
Handledare
  • Konttinen, Yrjö T., Handledare
  • Eklund, Kari, Handledare
  • Hagström, Jaana, Handledare
Sponsorer för avhandling
UtgivningsortHelsinki
Förlag
Tryckta ISBN978-951-51-5118-6
Elektroniska ISBN978-951-51-5119-3
StatusPublicerad - 9 apr 2019
MoE-publikationstypG5 Doktorsavhandling (artikel)

Vetenskapsgrenar

  • 3121 Inre medicin

Citera det här

@phdthesis{83a61ca6d40041cca000529f00fbafa0,
title = "Histamine H4 Receptor: A Potential Novel Therapeutic Target in Oral Lichen Planus and Oral Tongue Cancer",
abstract = "Background and objective: Oral lichen planus (OLP) is a common immune disorder of the oral mucosa, which is categorized as an oral potentially malignant disorder (OPMD) to highlight its potential progression to oral cancer. Oral cancer commonly affects the mobile tongue as oral tongue squamous cell carcinoma (OTSCC), which has dismal prognosis. Histamine signals via four G protein-coupled histamine receptors (H1R-H4R). Classical H1R and H2R medications are ineffective in treating OLP or OTSCC patients. The discovery of H4R has paved the way for novel perspectives in histamine research by modulating immune responses. We therefore hypothesized that H4R is involved in the pathogenesis of OLP and may contribute to oral carcinogenesis. Materials and methods: Tissue samples from OLP, oral epithelial dysplasia (OED) and OTSCC patients, and from healthy control participants were utilized. The in vitro experiments were performed on normal human oral keratinocytes (HOKs), two OTSCC-derived cell lines (HSC-3 and SCC-25), normal salivary gland cells, in addition to supernatants from activated human mast cells (MCs). For in vitro internalization and functional assays, two specific H4R ligands (agonist HST-10, and inverse agonist ST-1007) were used. Protein expression of histamine receptors, transporters and metabolizing enzymes, and other antigens were assessed in tissue samples and cell lines by immunohistochemistry and immunofluorescence staining. The expression levels of mRNA were quantified by qRT-PCR and the highly-sensitive droplet-digital PCR technology. Western blotting assays were performed to assess apoptotic markers following H4R stimulation, while flow cytometry was used to study Annexin-V and PI labelling of dead cells. Histamine levels were analysed using high-performance liquid chromatography. Results: Briefly, H4R is expressed in healthy oral epithelial cells on mRNA and protein levels, and they were able to fully internalize H4R-ligands in a time-dependent manner. In contrast, samples from OLP, OED and OTSCC patients exhibited lower H4R level, which was negatively correlated with MC-count and OTSCC-grade. We also reported that normal HOKs are histamine-producing cells—fully equipped with histamine synthesizing, transporting and degrading molecules. Interestingly, OLP samples exhibit high levels of the histamine synthesizing and transporting molecules, whereas histamine degrading enzyme was strongly inhibited. HOKs showed a dose-dependent Lipopolysaccharides (LPS)-driven release of histamine, while high histamine levels inhibited epithelial adhesion molecules. We next showed that toll-like receptors (TLRs) are essential players in OLP. TLRs were upregulated in OLP lesions, particularly for TLR4, which is necessary for LPS signalling. Importantly, LPS and MC-mediators regulated several oral oncogenes, while H4R-stimulated cells revealed a marked resistance to apoptosis. Furthermore, LPS and histamine influenced human beta defensin 2 (hBD-2) expression, which was highly induced in OLP. Unexpectedly, hBD-2 protein was subsided in OTSCC tissues with a marked downregulation of its transcript in cancer cells. Histamine synergistically induced TNF-α- and IFN-γ-mediated hBD-2 production in HOKs. Interestingly, targeting H4R seems to regulate TNFα- and LPS-mediated expression of hBD-2. Conclusions: Briefly, human oral epithelial cells are “non-professional” histamine producing cells—capable to synthesize, release, and degrade low levels of endogenic histamine. High levels of histamine may downregulate H4R as well as key integrity molecules in HOKs and may enhance subsequent bacterial invasion in OLP. In this regard, our findings suggest a potential role of TLRs in OLP pathogenesis, by mediating LPS signalling and enhancing further immune response and histamine production. In addition, our results indicate that histamine/H4R crosstalk signalling with LPS and MCs could in part be involved in OLP and the potential inflammation-driven tumorigenesis. This was further supported by the ability of H4R to regulate cell apoptosis and modulate antibacterial response in HOKs. Further functional and preclinical studies are therefore warranted.",
keywords = "3121 Internal medicine",
author = "Abdelhakim Salem",
note = "M1 - 114 s. + liitteet",
year = "2019",
month = "4",
day = "9",
language = "English",
isbn = "978-951-51-5118-6",
series = "Dissertationes scholae doctoralis ad sanitatem investigandam Universitatis Helsinkiensis",
publisher = "Helsingin yliopisto",
number = "27/2019",
address = "Finland",

}

Histamine H4 Receptor : A Potential Novel Therapeutic Target in Oral Lichen Planus and Oral Tongue Cancer. / Salem, Abdelhakim.

Helsinki : Helsingin yliopisto, 2019. 114 s.

Forskningsoutput: AvhandlingDoktorsavhandlingSamling av artiklar

TY - THES

T1 - Histamine H4 Receptor

T2 - A Potential Novel Therapeutic Target in Oral Lichen Planus and Oral Tongue Cancer

AU - Salem, Abdelhakim

N1 - M1 - 114 s. + liitteet

PY - 2019/4/9

Y1 - 2019/4/9

N2 - Background and objective: Oral lichen planus (OLP) is a common immune disorder of the oral mucosa, which is categorized as an oral potentially malignant disorder (OPMD) to highlight its potential progression to oral cancer. Oral cancer commonly affects the mobile tongue as oral tongue squamous cell carcinoma (OTSCC), which has dismal prognosis. Histamine signals via four G protein-coupled histamine receptors (H1R-H4R). Classical H1R and H2R medications are ineffective in treating OLP or OTSCC patients. The discovery of H4R has paved the way for novel perspectives in histamine research by modulating immune responses. We therefore hypothesized that H4R is involved in the pathogenesis of OLP and may contribute to oral carcinogenesis. Materials and methods: Tissue samples from OLP, oral epithelial dysplasia (OED) and OTSCC patients, and from healthy control participants were utilized. The in vitro experiments were performed on normal human oral keratinocytes (HOKs), two OTSCC-derived cell lines (HSC-3 and SCC-25), normal salivary gland cells, in addition to supernatants from activated human mast cells (MCs). For in vitro internalization and functional assays, two specific H4R ligands (agonist HST-10, and inverse agonist ST-1007) were used. Protein expression of histamine receptors, transporters and metabolizing enzymes, and other antigens were assessed in tissue samples and cell lines by immunohistochemistry and immunofluorescence staining. The expression levels of mRNA were quantified by qRT-PCR and the highly-sensitive droplet-digital PCR technology. Western blotting assays were performed to assess apoptotic markers following H4R stimulation, while flow cytometry was used to study Annexin-V and PI labelling of dead cells. Histamine levels were analysed using high-performance liquid chromatography. Results: Briefly, H4R is expressed in healthy oral epithelial cells on mRNA and protein levels, and they were able to fully internalize H4R-ligands in a time-dependent manner. In contrast, samples from OLP, OED and OTSCC patients exhibited lower H4R level, which was negatively correlated with MC-count and OTSCC-grade. We also reported that normal HOKs are histamine-producing cells—fully equipped with histamine synthesizing, transporting and degrading molecules. Interestingly, OLP samples exhibit high levels of the histamine synthesizing and transporting molecules, whereas histamine degrading enzyme was strongly inhibited. HOKs showed a dose-dependent Lipopolysaccharides (LPS)-driven release of histamine, while high histamine levels inhibited epithelial adhesion molecules. We next showed that toll-like receptors (TLRs) are essential players in OLP. TLRs were upregulated in OLP lesions, particularly for TLR4, which is necessary for LPS signalling. Importantly, LPS and MC-mediators regulated several oral oncogenes, while H4R-stimulated cells revealed a marked resistance to apoptosis. Furthermore, LPS and histamine influenced human beta defensin 2 (hBD-2) expression, which was highly induced in OLP. Unexpectedly, hBD-2 protein was subsided in OTSCC tissues with a marked downregulation of its transcript in cancer cells. Histamine synergistically induced TNF-α- and IFN-γ-mediated hBD-2 production in HOKs. Interestingly, targeting H4R seems to regulate TNFα- and LPS-mediated expression of hBD-2. Conclusions: Briefly, human oral epithelial cells are “non-professional” histamine producing cells—capable to synthesize, release, and degrade low levels of endogenic histamine. High levels of histamine may downregulate H4R as well as key integrity molecules in HOKs and may enhance subsequent bacterial invasion in OLP. In this regard, our findings suggest a potential role of TLRs in OLP pathogenesis, by mediating LPS signalling and enhancing further immune response and histamine production. In addition, our results indicate that histamine/H4R crosstalk signalling with LPS and MCs could in part be involved in OLP and the potential inflammation-driven tumorigenesis. This was further supported by the ability of H4R to regulate cell apoptosis and modulate antibacterial response in HOKs. Further functional and preclinical studies are therefore warranted.

AB - Background and objective: Oral lichen planus (OLP) is a common immune disorder of the oral mucosa, which is categorized as an oral potentially malignant disorder (OPMD) to highlight its potential progression to oral cancer. Oral cancer commonly affects the mobile tongue as oral tongue squamous cell carcinoma (OTSCC), which has dismal prognosis. Histamine signals via four G protein-coupled histamine receptors (H1R-H4R). Classical H1R and H2R medications are ineffective in treating OLP or OTSCC patients. The discovery of H4R has paved the way for novel perspectives in histamine research by modulating immune responses. We therefore hypothesized that H4R is involved in the pathogenesis of OLP and may contribute to oral carcinogenesis. Materials and methods: Tissue samples from OLP, oral epithelial dysplasia (OED) and OTSCC patients, and from healthy control participants were utilized. The in vitro experiments were performed on normal human oral keratinocytes (HOKs), two OTSCC-derived cell lines (HSC-3 and SCC-25), normal salivary gland cells, in addition to supernatants from activated human mast cells (MCs). For in vitro internalization and functional assays, two specific H4R ligands (agonist HST-10, and inverse agonist ST-1007) were used. Protein expression of histamine receptors, transporters and metabolizing enzymes, and other antigens were assessed in tissue samples and cell lines by immunohistochemistry and immunofluorescence staining. The expression levels of mRNA were quantified by qRT-PCR and the highly-sensitive droplet-digital PCR technology. Western blotting assays were performed to assess apoptotic markers following H4R stimulation, while flow cytometry was used to study Annexin-V and PI labelling of dead cells. Histamine levels were analysed using high-performance liquid chromatography. Results: Briefly, H4R is expressed in healthy oral epithelial cells on mRNA and protein levels, and they were able to fully internalize H4R-ligands in a time-dependent manner. In contrast, samples from OLP, OED and OTSCC patients exhibited lower H4R level, which was negatively correlated with MC-count and OTSCC-grade. We also reported that normal HOKs are histamine-producing cells—fully equipped with histamine synthesizing, transporting and degrading molecules. Interestingly, OLP samples exhibit high levels of the histamine synthesizing and transporting molecules, whereas histamine degrading enzyme was strongly inhibited. HOKs showed a dose-dependent Lipopolysaccharides (LPS)-driven release of histamine, while high histamine levels inhibited epithelial adhesion molecules. We next showed that toll-like receptors (TLRs) are essential players in OLP. TLRs were upregulated in OLP lesions, particularly for TLR4, which is necessary for LPS signalling. Importantly, LPS and MC-mediators regulated several oral oncogenes, while H4R-stimulated cells revealed a marked resistance to apoptosis. Furthermore, LPS and histamine influenced human beta defensin 2 (hBD-2) expression, which was highly induced in OLP. Unexpectedly, hBD-2 protein was subsided in OTSCC tissues with a marked downregulation of its transcript in cancer cells. Histamine synergistically induced TNF-α- and IFN-γ-mediated hBD-2 production in HOKs. Interestingly, targeting H4R seems to regulate TNFα- and LPS-mediated expression of hBD-2. Conclusions: Briefly, human oral epithelial cells are “non-professional” histamine producing cells—capable to synthesize, release, and degrade low levels of endogenic histamine. High levels of histamine may downregulate H4R as well as key integrity molecules in HOKs and may enhance subsequent bacterial invasion in OLP. In this regard, our findings suggest a potential role of TLRs in OLP pathogenesis, by mediating LPS signalling and enhancing further immune response and histamine production. In addition, our results indicate that histamine/H4R crosstalk signalling with LPS and MCs could in part be involved in OLP and the potential inflammation-driven tumorigenesis. This was further supported by the ability of H4R to regulate cell apoptosis and modulate antibacterial response in HOKs. Further functional and preclinical studies are therefore warranted.

KW - 3121 Internal medicine

M3 - Doctoral Thesis

SN - 978-951-51-5118-6

T3 - Dissertationes scholae doctoralis ad sanitatem investigandam Universitatis Helsinkiensis

PB - Helsingin yliopisto

CY - Helsinki

ER -

Salem A. Histamine H4 Receptor: A Potential Novel Therapeutic Target in Oral Lichen Planus and Oral Tongue Cancer. Helsinki: Helsingin yliopisto, 2019. 114 s. (Dissertationes scholae doctoralis ad sanitatem investigandam Universitatis Helsinkiensis; 27/2019).